Lista de obras -

A clinical model for identifying an inflammatory phenotype in mood disorders

scientific article published on 10 February 2019

A review of the neurobiology of obesity and the available pharmacotherapies

artículo científico publicado en 2017

Air pollution, aeroallergens and suicidality: a review of the effects of air pollution and aeroallergens on suicidal behavior and an exploration of possible mechanisms.

artículo científico publicado en 2017

Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression

scientific article published on 19 November 2018

Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review

scientific article published on 14 August 2018

Are early increases in physical activity a behavioral marker for successful antidepressant treatment?

artículo científico publicado en 2019

Association between cognitive function and performance on effort based decision making in patients with major depressive disorder treated with Vortioxetine

artículo científico publicado en 2019

Association of history of adverse childhood experiences with irritable bowel syndrome (IBS) in individuals with mood disorders

artículo científico publicado en 2020

Body Fat Changes and Liver Safety in Obese and Overweight Women Supplemented with Conjugated Linoleic Acid: A 12-Week Randomised, Double-Blind, Placebo-Controlled Trial

scientific article published on 17 June 2020

Brain insulin resistance: A treatment target for cognitive impairment and anhedonia in depression

artículo científico publicado en 2019

Changes in sleep predict changes in depressive symptoms in depressed subjects receiving vortioxetine: An open-label clinical trial

artículo científico publicado en 2019

Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: Results from the Canadian Rapid Treatment Center of Excellence

artículo científico publicado en 2020

Characterizing exercise-induced feelings after one bout of exercise among adolescents with and without bipolar disorder

artículo científico publicado en 2015

Characterizing the gut microbiota in adults with bipolar disorder: a pilot study

artículo científico publicado en 2019

Characterizing, Assessing, and Treating Cognitive Dysfunction in Major Depressive Disorder

scientific article published on 01 September 2018

Cognitive dysfunction and metabolic comorbidities in mood disorders: A repurposing opportunity for glucagon-like peptide 1 receptor agonists?

artículo científico publicado en 2018

Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder

artículo científico publicado en 2017

Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in Major Depressive Disorder

artículo científico publicado en 2018

Cognitive impairment in major depressive disorder

artículo científico publicado en 2018

Corrigendum to "Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review." J Affect Disord. 241 (2018) 519-532

artículo científico publicado en 2020

Drug-drug interactions as a result of co-administering Δ9-THC and CBD with other psychotropic agents.

artículo científico publicado en 2017

Effect of body anthropometrics on brain structure of offspring of parents with bipolar disorder

artículo científico publicado en 2020

Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial

scientific article published on 08 May 2019

Efficacy of Adjunctive Infliximab vs. Placebo in the Treatment of Anhedonia in Bipolar I/II Depression

scientific article published on 04 May 2020

Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review

artículo científico publicado en 2017

Effort-based decision-making is affected by overweight/obesity in major depressive disorder

scientific article published on 04 June 2019

Evidence supporting a mechanistic role of sirtuins in mood and metabolic disorders

artículo científico publicado en 2018

Expression of dopamine signaling genes in the post-mortem brain of individuals with mental illnesses is moderated by body mass index and mediated by insulin signaling genes

article

Extracellular Vesicle Biomarkers Reveal Inhibition of Neuroinflammation by Infliximab in Association with Antidepressant Response in Adults with Bipolar Depression

scientific article published on 06 April 2020

Inflammation: opportunities for treatment stratification among individuals diagnosed with mood disorders

artículo científico publicado en 2017

Is binge eating a cognitive disorder? Results from the International Mood Disorders Collaborative Project

artículo científico publicado en 2018

Ketogenic diet as a metabolic therapy for mood disorders: Evidence and developments

scientific article published on 31 July 2018

Leptin and adiponectin levels in major depressive disorder: A systematic review and meta-analysis

article

Leptin mediates improvements in cognitive function following treatment with infliximab in adults with bipolar depression

artículo científico publicado en 2020

Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study

artículo científico publicado en 2016

Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment

artículo científico publicado en 2020

Pain and major depressive disorder: Associations with cognitive impairment as measured by the THINC-integrated tool (THINC-it).

artículo científico publicado en 2017

Parsing metabolic heterogeneity in mood disorders: A hypothesis-driven cluster analysis of glucose and insulin abnormalities

scientific article published on 20 September 2019

Perceived sleep quality predicts cognitive function in adults with major depressive disorder independent of depression severity

artículo científico publicado en 2019

Peripheral interleukin-6 levels and working memory in non-obese adults: A post-hoc analysis from the CALERIE study

artículo científico publicado en 2018

Pharmacological Treatment of Cognitive Symptoms in Major Depressive Disorder

artículo científico publicado en 2017

Physical activity preferences of individuals diagnosed with schizophrenia or bipolar disorder

artículo científico publicado en 2016

Predicting antidepressant response using early changes in cognition: A systematic review

artículo científico publicado en 2018

Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder.

artículo científico publicado en 2018

Revisiting the International Physical Activity Questionnaire (IPAQ): Assessing sitting time among individuals with schizophrenia

artículo científico publicado en 2018

Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence

artículo científico publicado en 2020

Sex differences in the mediators of functional disability in Major Depressive Disorder.

artículo científico publicado en 2017

The Effectiveness of Ketamine on Anxiety, Irritability, and Agitation: Implications for Treating Mixed Features in Adults with Major Depressive or Bipolar Disorder

artículo científico publicado en 2020

The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder

artículo científico publicado en 2019

The Mental Health Effects of COVID-19 on Health Care Providers in China

artículo científico publicado en 2020

The Synergistic Effect of Social Media Use and Psychological Distress on Depression in China During the COVID-19 Epidemic

artículo científico publicado en 2020

The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive Disorder.

artículo científico publicado en 2017

The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change

artículo científico publicado en 2020

The effect of an acute bout of exercise on executive function among individuals with schizophrenia

artículo científico publicado en 2016

The effect of body mass index on glucagon-like peptide receptor gene expression in the post mortem brain from individuals with mood and psychotic disorders

article

The effect of caloric restriction on working memory in healthy non-obese adults

artículo científico publicado en 2020

The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis

artículo científico publicado en 2020

The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence

scientific article published on 26 May 2020

The impact of body mass index in gene expression of reelin pathway mediators in individuals with schizophrenia and mood disorders: A post-mortem study.

artículo científico publicado en 2018

The relationship between moderate-to-vigorous physical activity and executive function among individuals with schizophrenia: differences by illness duration

artículo científico publicado en 2017

The utility of smartphone-based, ecological momentary assessment for depressive symptoms

scientific article published on 25 May 2020

Treatment with a GLP-1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disorders

artículo científico publicado en 2017

Using early changes in cold cognition to predict response to vortioxetine in major depressive fisorder

scientific article published on 08 January 2020

Lista de obras de

A clinical model for identifying an inflammatory phenotype in mood disorders

A review of the neurobiology of obesity and the available pharmacotherapies

Air pollution, aeroallergens and suicidality: a review of the effects of air pollution and aeroallergens on suicidal behavior and an exploration of possible mechanisms.

Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression

Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review

Are early increases in physical activity a behavioral marker for successful antidepressant treatment?

Association between cognitive function and performance on effort based decision making in patients with major depressive disorder treated with Vortioxetine

Association of history of adverse childhood experiences with irritable bowel syndrome (IBS) in individuals with mood disorders

Body Fat Changes and Liver Safety in Obese and Overweight Women Supplemented with Conjugated Linoleic Acid: A 12-Week Randomised, Double-Blind, Placebo-Controlled Trial

Brain insulin resistance: A treatment target for cognitive impairment and anhedonia in depression

Changes in sleep predict changes in depressive symptoms in depressed subjects receiving vortioxetine: An open-label clinical trial

Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: Results from the Canadian Rapid Treatment Center of Excellence

Characterizing exercise-induced feelings after one bout of exercise among adolescents with and without bipolar disorder

Characterizing the gut microbiota in adults with bipolar disorder: a pilot study

Characterizing, Assessing, and Treating Cognitive Dysfunction in Major Depressive Disorder

Cognitive dysfunction and metabolic comorbidities in mood disorders: A repurposing opportunity for glucagon-like peptide 1 receptor agonists?

Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder

Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in Major Depressive Disorder

Cognitive impairment in major depressive disorder

Corrigendum to "Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review." J Affect Disord. 241 (2018) 519-532

Drug-drug interactions as a result of co-administering Δ9-THC and CBD with other psychotropic agents.

Effect of body anthropometrics on brain structure of offspring of parents with bipolar disorder

Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial

Efficacy of Adjunctive Infliximab vs. Placebo in the Treatment of Anhedonia in Bipolar I/II Depression

Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review

Effort-based decision-making is affected by overweight/obesity in major depressive disorder

Evidence supporting a mechanistic role of sirtuins in mood and metabolic disorders

Expression of dopamine signaling genes in the post-mortem brain of individuals with mental illnesses is moderated by body mass index and mediated by insulin signaling genes

Extracellular Vesicle Biomarkers Reveal Inhibition of Neuroinflammation by Infliximab in Association with Antidepressant Response in Adults with Bipolar Depression

Inflammation: opportunities for treatment stratification among individuals diagnosed with mood disorders

Is binge eating a cognitive disorder? Results from the International Mood Disorders Collaborative Project

Ketogenic diet as a metabolic therapy for mood disorders: Evidence and developments

Leptin and adiponectin levels in major depressive disorder: A systematic review and meta-analysis

Leptin mediates improvements in cognitive function following treatment with infliximab in adults with bipolar depression

Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study

Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment

Pain and major depressive disorder: Associations with cognitive impairment as measured by the THINC-integrated tool (THINC-it).

Parsing metabolic heterogeneity in mood disorders: A hypothesis-driven cluster analysis of glucose and insulin abnormalities

Perceived sleep quality predicts cognitive function in adults with major depressive disorder independent of depression severity

Peripheral interleukin-6 levels and working memory in non-obese adults: A post-hoc analysis from the CALERIE study

Pharmacological Treatment of Cognitive Symptoms in Major Depressive Disorder

Physical activity preferences of individuals diagnosed with schizophrenia or bipolar disorder

Predicting antidepressant response using early changes in cognition: A systematic review

Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder.

Revisiting the International Physical Activity Questionnaire (IPAQ): Assessing sitting time among individuals with schizophrenia

Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence

Sex differences in the mediators of functional disability in Major Depressive Disorder.

The Effectiveness of Ketamine on Anxiety, Irritability, and Agitation: Implications for Treating Mixed Features in Adults with Major Depressive or Bipolar Disorder

The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder

The Mental Health Effects of COVID-19 on Health Care Providers in China

The Synergistic Effect of Social Media Use and Psychological Distress on Depression in China During the COVID-19 Epidemic

The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive Disorder.

The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change

The effect of an acute bout of exercise on executive function among individuals with schizophrenia

The effect of body mass index on glucagon-like peptide receptor gene expression in the post mortem brain from individuals with mood and psychotic disorders

The effect of caloric restriction on working memory in healthy non-obese adults

The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis

The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence

The impact of body mass index in gene expression of reelin pathway mediators in individuals with schizophrenia and mood disorders: A post-mortem study.

The relationship between moderate-to-vigorous physical activity and executive function among individuals with schizophrenia: differences by illness duration

The utility of smartphone-based, ecological momentary assessment for depressive symptoms

Treatment with a GLP-1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disorders

Using early changes in cold cognition to predict response to vortioxetine in major depressive fisorder